Heterogeneity of soluble and nuclear oestrogen receptor status of involved nodes in relation to primary breast cancer. 1987

L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake

Both soluble and nuclear oestrogen receptors were measured in at least two different portions of primary breast cancer and in concurrent metastatic tissue from axillary nodes. Oestrogen receptor (ER) status of involved nodes was found highly consistent with that of primary tumours. Of the 67 patients studied, 30 had metastatic nodes which contained both soluble and nuclear ER. Of these, 27 were associated with a primary cancer which also had both soluble and nuclear ER, determined in at least two separate parts of the primary cancer. Conversely, none of the completely negative primaries gave rise to fully receptor positive metastatic tissue. Surprisingly, 17 out of 20 heterogeneous primary tumours, i.e. those containing both receptor positive and negative components, generated receptor negative metastatic nodes. Moreover, in 7 of the 8 patients with N-2 stage nodal involvement, the metastatic disease had arisen from primaries which were either completely receptor negative or with a heterogeneous ER status. It is suggested that macroscopic heterogeneity of ER status in primary breast cancer is associated with poor prognosis.

UI MeSH Term Description Entries
D008198 Lymph Nodes They are oval or bean shaped bodies (1 - 30 mm in diameter) located along the lymphatic system. Lymph Node,Node, Lymph,Nodes, Lymph
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011960 Receptors, Estrogen Cytoplasmic proteins that bind estrogens and migrate to the nucleus where they regulate DNA transcription. Evaluation of the state of estrogen receptors in breast cancer patients has become clinically important. Estrogen Receptor,Estrogen Receptors,Estrogen Nuclear Receptor,Estrogen Receptor Type I,Estrogen Receptor Type II,Estrogen Receptors Type I,Estrogen Receptors Type II,Receptor, Estrogen Nuclear,Receptors, Estrogen, Type I,Receptors, Estrogen, Type II,Nuclear Receptor, Estrogen,Receptor, Estrogen
D001943 Breast Neoplasms Tumors or cancer of the human BREAST. Breast Cancer,Breast Tumors,Cancer of Breast,Breast Carcinoma,Cancer of the Breast,Human Mammary Carcinoma,Malignant Neoplasm of Breast,Malignant Tumor of Breast,Mammary Cancer,Mammary Carcinoma, Human,Mammary Neoplasm, Human,Mammary Neoplasms, Human,Neoplasms, Breast,Tumors, Breast,Breast Carcinomas,Breast Malignant Neoplasm,Breast Malignant Neoplasms,Breast Malignant Tumor,Breast Malignant Tumors,Breast Neoplasm,Breast Tumor,Cancer, Breast,Cancer, Mammary,Cancers, Mammary,Carcinoma, Breast,Carcinoma, Human Mammary,Carcinomas, Breast,Carcinomas, Human Mammary,Human Mammary Carcinomas,Human Mammary Neoplasm,Human Mammary Neoplasms,Mammary Cancers,Mammary Carcinomas, Human,Neoplasm, Breast,Neoplasm, Human Mammary,Neoplasms, Human Mammary,Tumor, Breast
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001706 Biopsy Removal and pathologic examination of specimens from the living body. Biopsies

Related Publications

L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
January 1981, British journal of cancer,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
May 1987, British journal of cancer,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
October 1977, Lancet (London, England),
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
September 1985, Seminars in oncology,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
August 1979, Lancet (London, England),
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
June 1981, Lancet (London, England),
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
September 1981, British journal of cancer,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
August 1989, British journal of cancer,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
April 1995, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
L Castagnetta, and A Traina, and A Di Carlo, and A M Latteri, and G Carruba, and R E Leake
April 1985, Lancet (London, England),
Copied contents to your clipboard!